These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 15916087
1. Prevalence and antimicrobial susceptibility of Pseudomonas aeruginosa mucoid and non-mucoid type. Srifuengfung S, Tiensasitorn C, Yungyuen T, Dhiraputra C. Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):893-6. PubMed ID: 15916087 [Abstract] [Full Text] [Related]
2. Antimicrobial use and Pseudomonas aeruginosa susceptibility profile in a cystic fibrosis centre. Manno G, Cruciani M, Romano L, Scapolan S, Mentasti M, Lorini R, Minicucci L. Int J Antimicrob Agents; 2005 Mar; 25(3):193-7. PubMed ID: 15737511 [Abstract] [Full Text] [Related]
3. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey. Yetkin G, Otlu B, Cicek A, Kuzucu C, Durmaz R. Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175 [Abstract] [Full Text] [Related]
4. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics. Khan JA, Iqbal Z, Rahman SU, Farzana K, Khan A. Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431 [Abstract] [Full Text] [Related]
5. [Contribution of Pseudomonas Aeruginosa strains to infections in patients of specialistic outpatients clinics of the SP ZOZ in Nidzica]. Pszenna M, Rokosz A, Luczak M. Med Dosw Mikrobiol; 2005 Jul; 57(4):417-24. PubMed ID: 16773835 [Abstract] [Full Text] [Related]
6. Comparative study of the biological characteristics of mucoid and non-mucoid Pseudomonas aeruginosa strains isolated from chronic respiratory infections. Meitert E, Sima F, Savulian C, Chersulick E, Sălăgeanu A. Arch Roum Pathol Exp Microbiol; 1989 Jul; 48(3):193-207. PubMed ID: 2519631 [Abstract] [Full Text] [Related]
7. Nosocomial cross-transmission of Pseudomonas aeruginosa between patients in a tertiary intensive care unit. Mayank D, Anshuman M, Singh RK, Afzal A, Baronia AK, Prasad KN. Indian J Pathol Microbiol; 2009 Jul; 52(4):509-13. PubMed ID: 19805958 [Abstract] [Full Text] [Related]
8. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units. Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO. Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562 [Abstract] [Full Text] [Related]
9. [Susceptibility patterns of Pseudomonas aeruginosa strains isolated in the Monastir region, Tunisia]. Abdallah HB, Noomen S, Khélifa AB, Sahnoun O, Elargoubi A, Mastouri M. Med Mal Infect; 2008 Oct; 38(10):554-6. PubMed ID: 18814981 [Abstract] [Full Text] [Related]
10. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. Raja NS, Singh NN. J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906 [Abstract] [Full Text] [Related]
11. Antibiotic susceptibility patterns and clones of Pseudomonas aeruginosa in Swedish ICUs. Erlandsson M, Gill H, Nordlinder D, Giske CG, Jonas D, Nilsson LE, Walther S, Hanberger H. Scand J Infect Dis; 2008 Feb; 40(6-7):487-94. PubMed ID: 18584536 [Abstract] [Full Text] [Related]
12. [Drug susceptibility of Pseudomonas aeruginosa strains isolated from patients of a hospital and specialistic outpatients clinics of the SP ZOZ in Nidzica]. Pszenna M, Rokosz A, Luczak M. Med Dosw Mikrobiol; 2005 Feb; 57(3):303-10. PubMed ID: 16494207 [Abstract] [Full Text] [Related]
13. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005. Dejsirilert S, Suankratay C, Trakulsomboon S, Thongmali O, Sawanpanyalert P, Aswapokee N, Tantisiriwat W. J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S68-75. PubMed ID: 21298847 [Abstract] [Full Text] [Related]
14. [Antimicrobial susceptibility and serotyping of Pseudomonas aeruginosa isolated from HIV/AIDS patients]. Rodríguez DS, Rizo AG, Monroy SP, Reyes T. Rev Cubana Med Trop; 2002 Aug; 54(2):142-6. PubMed ID: 15849941 [Abstract] [Full Text] [Related]
15. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II. Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923 [Abstract] [Full Text] [Related]
16. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand. Koomanachai P, Tiengrim S, Kiratisin P, Thamlikitkul V. Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803 [Abstract] [Full Text] [Related]
17. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil. Zavascki AP, Gaspareto PB, Martins AF, Gonçalves AL, Barth AL. J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284 [Abstract] [Full Text] [Related]
18. Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Hsueh PR, Tseng SP, Teng LJ, Ho SW. Clin Microbiol Infect; 2005 Aug; 11(8):670-3. PubMed ID: 16008621 [Abstract] [Full Text] [Related]
19. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients. Nazik H, Ongen B, Erturan Z, Salcioğlu M. Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637 [Abstract] [Full Text] [Related]
20. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Obritsch MD, Fish DN, MacLaren R, Jung R. Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180 [Abstract] [Full Text] [Related] Page: [Next] [New Search]